Peptides DB
Research-centric peptide and protocol reference hub
Study 12 of 12Vipivotide literaturePlant science : an international journal of experimental plant biology · Observational2026

Identification and functional verification of resistance genes against Lily bulb virus-1 (LbV-1) in Lilium: Insight from sRNA sequencing and transcriptomic profiling.

The study highlights the importance of screening commercial lily bulbs for latent viral infections and identifies potential genetic resistance mechanisms against LbV-1.

Read at Plant science : an international journal of experimental plant biologyAdd to compare

Where it sits

this study against the rest of the vipivotide corpus
3
Preclinical
7
Observational · this one
0
Open-label
2
Randomised
0
Reviews

Summary and findings

This study identified and characterized a novel mitovirus, Lily Bulb Virus-1 (LbV-1), in commercial lily bulb stocks. A survey of 50 lily bulbs revealed LbV-1 infection in a single cultivar, with an infection rate of up to 45% in progeny plants. Eight candidate genes were significantly upregulated in response to LbV-1 infection, with seven enhancing viral resistance when expressed in susceptible plants.

How much of this paper we could read: full text read (0.80). We had a clear abstract, so the summary below closely tracks the paper. What this means →
Infection rate of up to 45% in progeny plants.2026

Abstract

The authors’ words, as Plant science : an international journal of experimental plant biology supplied them

Lilium is an economically important genus widely cultivated for ornamental and commercial use. In this study, we report the identification and characterization of a novel mitovirus, designated Lily Bulb Virus-1 (LbV-1), detected in commercial lily bulb stocks. This virus represents a previously uncharacterized member of the mitochondrial RNA virus group associated with lily crops. A survey of 50 commercially cultivated lily bulbs, including Lilium longiflorum varieties, revealed LbV-1 infection in a single cultivar, indicating a low but detectable incidence under the tested conditions. Although infected plants exhibited no visible symptoms during in vitro cultivation, the presence of LbV-1 was confirmed through PCR amplification, small RNA (sRNA) sequencing, transmission electron microscopy (TEM), and mechanical inoculation assays. A total of 9122,220 unique sRNA reads were identified, with 21-22 nt virus-derived small RNAs mapping to the LbV-1 genome, supporting active host-virus interaction. Additionally, transcriptome-based analyses indicated efficient bulb-mediated transmission, with an infection rate of up to 45% in progeny plants. Comparative transcriptomic analysis of infected and healthy bulbs yielded over 30 million high-quality reads, resulting in the assembly of 3671,77 transcripts and 168,004 unigenes with an average length of 1445 bp. Differential expression analysis identified eight candidate genes (Li-PCP, Li-DUF, Li-UBD, Li-FRC, Li-CF, Li-APD, Li1-UN, and Li7-UN) that were significantly upregulated in response to LbV-1 infection and validated across three developmental stages using RT-qPCR. Functional analysis demonstrated that seven of these genes enhanced viral resistance when expressed in susceptible lily plants. These findings provide new insights into the molecular biology, transmission dynamics, and host defense responses associated with LbV-1. This study highlights the importance of systematic screening of commercial lily bulb stocks to prevent the unnoticed spread of latent viral infections and to safeguard sustainable lily production systems.

Elsewhere in the Vipivotide corpus

DClinical and economic outcomes of cabazitaxel versus Lu-PSMA in mCRPC: a US perspective.Journal of medical economics · 2026 · 66% PSA response for Lu-PSMA vs 37% for cabazitaxel, p<0.0001.reviewDPlitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A.Science (New York, N.Y.) · 2021DSARS-CoV-2 dependence on host pathways.Science (New York, N.Y.) · 2021DHundreds of COVID trials could provide a deluge of new drugs.Nature · 2022B[&lt;sup&gt;177&lt;/sup&gt;Lu]Lu-PSMA radioligand therapy in younger prostate cancer patients: A matched-pair analysis between patients ≤ 65 and ≥ 70 years old.European journal of nuclear medicine and molecular imaging · 2023 · n=102 · No significant differences were observed for PFS (P=0.882) and OS (P=0.17).HumanBClinical value of per-treatment whole-body single-time-point automated dosimetry for [&lt;sup&gt;177&lt;/sup&gt;Lu]Lu-PSMA-617 therapy in metastatic castration-resistant prostate cancer.European journal of nuclear medicine and molecular imaging · 2023 · n=59 · Bone marrow absorbed dose (BMAD) at C1 was significantly correlated with red blood cells (RBC, ρ = -0.3) and hemoglobin (ρ = -0.26) decline.Human